LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "cgrp mab" as a keyword



Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) study

Sign Up to like & get
recommendations! Published in 2025 at "Cephalalgia"

DOI: 10.1177/03331024251341243

Abstract: Background Understanding characteristics and reasons associated with using calcitonin gene-related peptide monoclonal antibodies (CGRP mAb) for migraine prevention may help clinicians individualize treatment plans and achieve better patient outcomes. Methods We analyzed 2019–2020 cohort data… read more here.

Keywords: use; related peptide; gene related; calcitonin gene ... See more keywords

Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study

Sign Up to like & get
recommendations! Published in 2022 at "Patient preference and adherence"

DOI: 10.2147/ppa.s346660

Abstract: Background Most conventional, oral, preventive treatments for migraine are non-specific and ~50% of patients discontinue them within six months. In 2018, the Food and Drug Administration approved three preventive migraine treatments: monoclonal antibodies (mAb) targeting… read more here.

Keywords: preventive treatments; month; cgrp mab; galcanezumab versus ... See more keywords

Early Effect of Calcitonin Gene-related Peptide Monoclonal Antibodies in Migraine with Medication Overuse: A Single-center Retrospective Study.

Sign Up to like & get
recommendations! Published in 2023 at "Internal medicine"

DOI: 10.2169/internalmedicine.1471-22

Abstract: Objective Calcitonin gene-related peptide (CGRP)-(receptor) monoclonal antibody (mAb) has been reported to reduce the frequency of medication overuse in patients with migraine. The present study investigated whether or not CGRP-mAb treatment shows early effectiveness for… read more here.

Keywords: mab; medication overuse; study; cgrp mab ... See more keywords

Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine

Sign Up to like & get
recommendations! Published in 2021 at "Frontiers in Neurology"

DOI: 10.3389/fneur.2021.788159

Abstract: Background: OnabotulinumtoxinA and calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) target different migraine pathways, therefore, combination treatment may provide additional effectiveness for the preventive treatment of chronic migraine (CM) than either treatment alone. The objective… read more here.

Keywords: safety; combination; treatment; real world ... See more keywords